Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 321-328

  Domitrović, Robert ^a   Potočnjak, Iva ^a   Crnčević Orlić, Željka ^b   Škoda, Marko ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

Apoptosis; Cisplatin; Inflammation; Nephrotoxicity; Oxidative stress; Rosmarinic acid

Indexed keywords

4 HYDROXYNONENAL; CASPASE 3; CISPLATIN; CREATININE; CYTOCHROME P450 2E1; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITROGEN; PROTEIN P53; ROSMARINIC ACID; TUMOR NECROSIS FACTOR ALPHA; UREA; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CINNAMIC ACID DERIVATIVE; DEPSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG ACTIVITY; DRUG MEGADOSE; HISTOPATHOLOGY; KIDNEY INJURY; MALE; MOUSE; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CYTOLOGY; DRUG EFFECTS; KIDNEY; ORGAN SIZE; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; CINNAMATES; CISPLATIN; DEPSIDES; KIDNEY; MALE; MICE; MICE, INBRED BALB C; ORGAN SIZE;

EID: 84896878441     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.02.002     Document Type: Article

References (62)

1. Amaral J.D., Xavier J.M., Steer C.J., et al. The role of p53 in apoptosis. Discov. Med. 2010, 9:145-152.
2. Amin A., Abraham C., Hamza A.A., et al. A standardized extract of Ginkgo biloba neutralizes CP-mediated reproductive toxicity in rats. J. Biomed. Biotechnol. 2012, 2012:362049.
3. Bragado P., Armesilla A., Silva A., et al. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 2007, 12:1733-1742.
4. Brahmi D., Ayed Y., Hfaiedh M., et al. Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice. combination with phytochemical composition. BMC Complement. Altern. Med. 2012, 12:111.
5. Chirino Y.I., Trujillo J., Sánchez-González D.J., et al. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol. Lett. 2008, 176:48-57.
6. Chirino Y.I., Sánchez-González D.J., Martínez-Martínez C.M., et al. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008, 245:18-23.
7. Chu X., Ci X., He J., et al. Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice. Molecules 2012, 17:3586-3598.
8. Coca S.G., Parikh C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. 2008, 3:481-490.
9. Costa R.S., Carneiro T.C., Cerqueira-Lima A.T., et al. Ocimum gratissimum Linn. and rosmarinic acid, attenuate eosinophilic airway inflammation in an experimental model of respiratory allergy to Blomia tropicalis. Int. Immunopharmacol. 2012, 13:126-134.
10. Davis C.A., Nick H.S., Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J. Am. Soc. Nephrol. 2001, 12:2683-2690.
11. Domitrović R., Škoda M., Vasiljev Marchesi V. Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice. Food Chem. Toxicol. 2013, 51:370-378.
12. Domitrović R., Jakovac H., Marchesi V.V., et al. Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice. Pharmacol. Res. 2012, 65:451-464.
13. 4-intoxicated mice. Toxicology 2011, 280:33-43.
14. Domitrović R., Jakovac H., Milin Č., Radošević-Stasić B. Dose- and time-dependent effects of luteolin on carbon tetrachloride-induced hepatotoxicity in mice. Exp. Toxicol. Pathol. 2009, 61:581-589.
15. Francescato H.D.C., Costa R.S., Scavone C., et al. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007, 230:64-75.
16. Giaccone G. Clinical perspectives on platinum resistance. Drugs 2009, 59:9-17.
17. Hartmann J.T., Lipp H.P. Toxicity of platinum compounds. Expert Opin. Pharmacother. 2003, 4:889-901.
18. Hassan I., Chibber S., Khan A.A., et al. Riboflavin ameliorates cisplatin induced toxicities under photoillumination. PLoS One 2012, 7:e36273.
19. Jia Z., Wang N., Aoyagi T., et al. Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int. 2011, 79:77-88.
20. Jiang M., Yi X., Hsu S., Wang C.Y., et al. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am. J. Physiol. Renal Physiol. 2004, 287:F1140-F1147.
21. Kang K.P., Park S.K., Kim D.H., et al. Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis. Nephrol. Dial. Transplant. 2011, 26:814-822.
22. Kannan K., Jain S.K. Oxidative stress and apoptosis. Pathophysiology 2000, 7:153-163.
23. Kaushal G., Kaushal V., Hong X., et al. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001, 60:1726-1736.
24. Kimura Y., Ito H., Ohnishi R., et al. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol. 2010, 48:429-435.
25. Kusirisin W., Jaikang C., Chaiyasut C., et al. Effect of polyphenolic compounds from Solanum torvum on plasma lipid peroxidation, superoxide anion and cytochrome P450 2E1 in human liver microsomes. Med. Chem. 2009, 5:583-588.
26. Lee H.J., Cho H.S., Park E., et al. Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis. Toxicology 2008, 250:109-115.
27. Leemans J.C., Stokman G., Claessen N., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 2005, 115:2894-2903.
28. Leonetti C., Biroccio A., Gabellini C., et al. Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. Int. J. Cancer 2003, 104:243-250.
29. Liu H., Baliga M., Baliga R. Effect of cytochrome P450 2E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res. 2002, 22:863-868.
30. Liu H., Baliga R. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003, 63:1687-1696.
31. Matsushima H., Yonemura K., Ohishi K., et al. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J. Lab. Clin. Med. 1998, 131:518-526.
32. Miller R.P., Tadagavadi R.K., Ramesh, et al. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2010, 2:2490-2518.
33. Moreno S., Scheyer T., Romano C.S., et al. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic. Res. 2006, 40:223-231.
34. Muller D.N., Schmidt C., Barbosa-Sicard E., et al. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem. J. 2007, 403:109-118.
35. Ninsontia C., Pongjit K., Chaotham C., et al. Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharm. Biol. 2011, 49:1082-1090.
36. Offer H., Erez N., Zurer I., et al. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 2002, 23:1025-1032.
37. Özgen U., Mavi A., Terzi Z., et al. Relationship between chemical structure and antioxidant activity of luteolin and its glycosides isolated from Thymus sipyleus subsp. sipyleus var. sipyleus. Rec. Nat. Prod. 2011, 5:12-21.
38. Pabla N., Huang S., Mi Q.S., et al. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J. Biol. Chem. 2008, 283:6572-6583.
39. Pan H., Shen Z., Mukhopadhyay P., et al. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. Am. J. Physiol. Renal Physiol. 2009, 296:F496-F504.
40. Park J.W., Cho J.W., Joo S.Y., et al. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. Eur. J. Pharmacol. 2012, 683:301-309.
41. Petersen M., Simmonds M.S. Rosmarinic acid. Phytochemistry 2003, 62:121-125.
42. Ramesh G., Reeves W.B. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α. Kidney Int. 2004, 65:490-498.
43. Sakaguchi K., Herrera J.E., Saito S., et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998, 12:2831-2841.
44. Sakihama Y., Cohen M.F., Grace S.C., et al. Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants. Toxicology 2002, 177:67-80.
45. Sahu B.D., Kuncha M., Sindhura G.J., et al. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine 2013, 20:453-460.
46. Sahu B.D., Reddy K.K.R., Putcha U.K., et al. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem. Toxicol. 2011, 49:3090-3097.
47. Sanchez-Gonzalez P.D., Lopez-Hernandez F.J., Perez-Barriocanal F., et al. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol. Dial. Transplant. 2011, 26:3484-3495.
48. Schrier R.W., Wang W., Poole B., et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 2004, 114:5-14.
49. Shen Y., White E. P53-dependent apoptosis pathways. Adv. Cancer Res. 2001, 82:55-84.
50. Shino Y., Itoh Y., Kubota T., et al. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells. Free Radic. Biol. Med. 2003, 35:966-997.
51. Sroka Z., Cisowski W. Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem. Toxicol. 2003, 41:753-758.
52. Sung M.J., Kim D.H., Jung Y.J., et al. Genistein protects the kidney from cisplatin-induced injury. Kidney Int. 2008, 74:1538-1547.
53. Swarup V., Ghosh J., Ghosh S., et al. Antiviral and antiinflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob. Agents Chemother. 2007, 51:3367-3370.
54. Tanabe K., Tamura Y., Lanaspa M.A., et al. Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy. Am. J. Physiol. Renal Physiol. 2012, 303:F1264-F1274.
55. Tavafi M., Ahmadvand H. Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats. Tissue Cell 2011, 43:392-397.
56. Venkatachalam K., Gunasekaran S., Jesudoss V.A., et al. The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis. Exp. Toxicol. Pathol. 2013, 65:409-418.
57. Vijayan F.P., Rani V.K., Vineesh V.R., et al. Protective effect of Cyclea peltata Lam on cisplatin-induced nephrotoxicity and oxidative damage. J. Basic Clin. Physiol. Pharmacol. 2007, 18:101-114.
58. Wang Y., Lee K.W., Chan F.L., et al. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol. Sci. 2006, 92:71-77.
59. Wei Q., Dong G., Yang T., et al. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am. J. Physiol. Ren. Physiol. 2007, 293:F1282-F1291.
60. Wu C.T., Sheu M.L., Tsai K.S., et al. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. Free Radic. Biol. Med. 2011, 51:671-680.
61. Yao X., Panichpisal K., Kurtzman N., et al. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007, 334:115-124.
62. Zhang Y., Li X., Wang Z. Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related phenolic constituents. Food Chem. Toxicol. 2010, 48:2656-2662.